Inventor · disambiguated record
Jasenka Matulic-Adamic
Also filed as: MATULIC-ADAMIC JASENKA
30 granted patents·7 pending applications·3,310 citations·filing 1985–2012
98Inventor score
Files withRIBOZYME PHARM INC22SIRNA THERAPEUTICS INC9BEIGELMAN LEONID1INTERMUNE INC1MATULIC-ADAMIC JASENKA1
Top patents by PatentIndex Score
37 records- 0198US8188247B2Conjugates and compositions for cellular deliveryBEIGELMAN LEONID·Filed 2010·Granted May 29, 2012·36 cites·3 claims
- 0298US7109165B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2002·Granted Sep 19, 2006·90 cites·74 claims
- 0398US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0498US6362323B1Non-nucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 2000·Granted Mar 26, 2002·179 cites·7 claims
- 0598US6117657ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1998·Granted Sep 12, 2000·253 cites·13 claims
- 0698US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 0797US7858625B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2005·Granted Dec 28, 2010·22 cites·2 claims
- 0897US6849726B2Non-nucleotide containing RNASIRNA THERAPEUTICS INC·Filed 2003·Granted Feb 1, 2005·129 cites·12 claims
- 0997US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 1097US6248878B1Nucleoside analogsRIBOZYME PHARM INC·Filed 1997·Granted Jun 19, 2001·264 cites·16 claims
- 1196US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 1296US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 1395US7553830B2Compositions for the delivery of negatively charged moleculesSIRNA THERAPEUTICS INC·Filed 2005·Granted Jun 30, 2009·20 cites·10 claims
- 1493US8461313B2Conjugates and compositions for cellular deliveryMATULIC-ADAMIC JASENKA·Filed 2012·Granted Jun 11, 2013·18 cites·11 claims
- 1591US5891683ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·104 cites·16 claims
- 1689US6797815B2Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesSIRNA THERAPEUTICS INC·Filed 2002·Granted Sep 28, 2004·16 cites·16 claims
- 1783US6586238B1Enzymatic nucleic acids containing 5′-and or 3′-cap structuresRIBOZYME PHARM INC·Filed 1999·Granted Jul 1, 2003·43 cites·20 claims
- 1883US6489465B2Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesRIBOZYME PHARM INC·Filed 2001·Granted Dec 3, 2002·7 cites·20 claims
- 1977US6509460B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 2000·Granted Jan 21, 2003·4 cites·12 claims
- 2077US6093555AAmido and peptido modified enzymatic nucleic acid moleculesRIBOZYME PHARM INC·Filed 1998·Granted Jul 25, 2000·30 cites·11 claims
- 2176US6555668B2Non-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 2002·Granted Apr 29, 2003·2 cites·11 claims
- 2275US4762823ANucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracilSLOAN KETTERING INST CANCER·Filed 1985·Granted Aug 9, 1988·24 cites·10 claims
- 2374US6379954B1Amido and peptido modified catalytic oligonucleotidesRIBOZYME PHARM INC·Filed 2000·Granted Apr 30, 2002·2 cites·10 claims
- 2473US2010036115A1Novel Compositions for the Delivery of Negatively Charged MoleculesSIRNA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2570US6127535ANucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·23 cites·20 claims
- 2669US5783425AAmino and peptido modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Jul 21, 1998·22 cites·16 claims
- 2767US5672501ABase-modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted Sep 30, 1997·20 cites·16 claims
- 2866US6482932B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1999·Granted Nov 19, 2002·21 cites·20 claims
- 2961US6316612B1Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesRIBOZYME PHARM INC·Filed 1998·Granted Nov 13, 2001·11 cites·29 claims
- 3058US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 3157US2005074760A1Enzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
- 3251US2009047246A1Novel inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 3350US2003130186A1Conjugates and compositions for cellular deliveryFiled 2002·Application pending·0 cites
- 3445US5506349AChemical synthesis of 2', 3'-dideoxycytidineRIBOZYME PHARM INC·Filed 1992·Granted Apr 9, 1996·4 cites·1 claims
- 3545US2003073640A1Novel compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 2001·Application pending·0 cites
- 3644US6268534B1Process for the synthesis of N,N-Dioleyl-N,N-Dimethylammonium ChlorideRIBOZYME PHARM INC·Filed 1999·Granted Jul 31, 2001·2 cites·19 claims
- 3743US2003004122A1Nucleotide triphosphates and their incorporation into oligonucleotidesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →